Examining the potential of natural and novel synthetic cannabinoids for targeted cancer treatment based on their molecular mechanisms.
The vast chemical space available through stereoselective synthesis using starting materials and reaction sequences not previously explored holds a promise of a substantial breakthrough in identifying new therapeutic agents.
In partnership with the National Cancer Institute of Lithuania, Sanobiotec is examining the potential of natural and novel synthetic cannabinoids for targeted cancer treatment based on their molecular mechanisms. Starting with in vitro experiments, the scientific teams are exploring the bioactivity of a vast range of different cannabinoids identifying the most promising ones and conducting their further evaluation.
The National Cancer Institute is conducting molecular studies of anti-cancer effects of cannabinoids in contemporary 3D cell cultures and in vivo models.
Sanobiotec’s upcoming research is a joint project with the Life Sciences Centre of Vilnius University and will explore the promising potential of cannabinoids in the treatment of Alzheimer’s disease and other neurodegenerative disorders.